Janney Montgomery Scott’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$332K Sell
3,114
-162
-5% -$19.6K ﹤0.01% 2672
2026
Q1
$536K Buy
3,276
+488
+18% +$75K ﹤0.01% 2000
2025
Q4
$485K Buy
+2,788
New +$509K ﹤0.01% 2213
2023
Q3
Sell
-20,753
Closed -$438K 2671
2023
Q2
$438K Buy
20,753
+4,065
+24% +$77.1K ﹤0.01% 1975
2023
Q1
$285K Buy
16,688
+2,091
+14% +$40.6K ﹤0.01% 2077
2022
Q4
$292K Buy
14,597
+2,108
+17% +$40.7K ﹤0.01% 2148
2022
Q3
$269K Sell
12,489
-1,366
-10% -$32.8K ﹤0.01% 2086
2022
Q2
$276K Buy
13,855
+2,045
+17% +$42.9K ﹤0.01% 1965
2022
Q1
$278K Buy
11,810
+3,289
+39% +$76.4K ﹤0.01% 1930
2021
Q4
$232K Sell
8,521
-398
-4% -$11.4K ﹤0.01% 2155
2021
Q3
$246K Sell
8,919
-856
-9% -$22.5K ﹤0.01% 2059
2021
Q2
$278K Buy
+9,775
New +$290K ﹤0.01% 1958

Other funds holding INSM

Janney Montgomery Scott's INSM Position: Q2 2026 in Review

Janney Montgomery Scott reduced its Insmed (INSM) stake by 4.9% in Q2 2026, selling an estimated $19.6K and leaving 3,114 shares worth $332K. The position accounts for ﹤0.01% of the portfolio, ranked #2672.

Janney Montgomery Scott first reported a position in INSM in Q2 2021 and has held it in 12 quarters since. The position peaked at $536K in Q1 2026. 666 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Janney Montgomery Scott held 3,114 shares of Insmed worth $332K as of Q2 2026.
  • Janney Montgomery Scott sold 162 Insmed shares in Q2 2026, an estimated $19.6K.
  • Insmed made up ﹤0.01% of Janney Montgomery Scott's portfolio in Q2 2026, its #2672 holding.
  • Janney Montgomery Scott first reported a position in Insmed in Q2 2021 and has held it in 12 quarters since.
  • Janney Montgomery Scott's Insmed position peaked at $536K in Q1 2026.
  • 666 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Janney Montgomery Scott's 13F filing for Q2 2026, filed 5 Aug 2026.